{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:36:04Z","timestamp":1790105764335,"version":"4.0.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000004792","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T12:53:32Z","timestamp":1473252812000},"page":"e4792","source":"Crossref","is-referenced-by-count":29,"title":["Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis"],"prefix":"10.1097","volume":"95","author":[{"given":"Li-Chih","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui-Ying","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Jieh","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Yuan","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-55-20210226","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"R2-55-20210226","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.61.suppl_3.iii40","article-title":"Conventional treatments for ankylosing spondylitis","volume":"61","author":"Dougados","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R3-55-20210226","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-55-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1074248407312990","article-title":"Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease","volume":"13","author":"Hennekens","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R5-55-20210226","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis","volume":"330","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"R6-55-20210226","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","article-title":"Antirheumatic drug use and the risk of acute myocardial infarction","volume":"55","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R7-55-20210226","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","article-title":"Mortality in ankylosing spondylitis: results from a nationwide population-based study","volume":"75","author":"Exarchou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R8-55-20210226","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","article-title":"Cardiovascular events in ankylosing spondylitis: an updated meta-analysis","volume":"44","author":"Mathieu","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"R11-55-20210226","first-page":"1520","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"VIGOR Study GrouN Engl J Med"},{"key":"R12-55-20210226","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"R13-55-20210226","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-55-20210226","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(02)11131-7","article-title":"COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease","volume":"360","author":"Ray","year":"2002","journal-title":"Lancet"},{"key":"R15-55-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archinte.163.4.481","article-title":"Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly","volume":"163","author":"Mamdani","year":"2003","journal-title":"Arch Intern Med"},{"key":"R16-55-20210226","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.0000127578.21885.3E","article-title":"Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults","volume":"109","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"R17-55-20210226","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.CIR.0000101683.30157.0B","article-title":"Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension","volume":"108","author":"Hermann","year":"2003","journal-title":"Circulation"},{"key":"R18-55-20210226","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.CIR.0000051361.69808.3A","article-title":"Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease","volume":"107","author":"Chenevard","year":"2003","journal-title":"Circulation"},{"key":"R19-55-20210226","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-142-3-200502010-00005","article-title":"Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction","volume":"142","author":"Kimmel","year":"2005","journal-title":"Ann Intern Med"},{"key":"R20-55-20210226","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:02Z","timestamp":1620959582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609060-00055"}},"subtitle":["A nation-wide, population-based case-control study"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004792","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}